These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38126694)

  • 1. Tumor Microenvironment-Specific Driven Nanoagents for Synergistic Mitochondria Damage-Related Immunogenic Cell Death and Alleviated Immunosuppression.
    Qian Y; Chen W; Wang M; Xie Y; Qiao L; Sun Q; Gao M; Li C
    Small Methods; 2024 Jul; 8(7):e2301231. PubMed ID: 38126694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Ding Y; Sun Z; Gao Y; Zhang S; Yang C; Qian Z; Jin L; Zhang J; Zeng C; Mao Z; Wang W
    Adv Mater; 2021 Aug; 33(34):e2102188. PubMed ID: 34278622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
    Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.
    Lu J; Liu X; Liao YP; Wang X; Ahmed A; Jiang W; Ji Y; Meng H; Nel AE
    ACS Nano; 2018 Nov; 12(11):11041-11061. PubMed ID: 30481959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression.
    Lu J; Liu X; Liao YP; Salazar F; Sun B; Jiang W; Chang CH; Jiang J; Wang X; Wu AM; Meng H; Nel AE
    Nat Commun; 2017 Nov; 8(1):1811. PubMed ID: 29180759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
    Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
    ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer.
    Zhang W; Chen G; Chen Z; Yang X; Zhang B; Wang S; Li Z; Yang Y; Wu Y; Liu Z; Yu Z
    J Control Release; 2024 Jul; 371():470-483. PubMed ID: 38849094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A coordinative modular assembly-constructed self-reinforced nano-therapeutic agent for effective antitumor-immune activation.
    Zheng Y; Bu F; Xu C; Wu T; Zhou J; Shen W; Yin T
    J Control Release; 2024 Jul; 371():588-602. PubMed ID: 38866245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment.
    Li Q; Liu J; Fan H; Shi L; Deng Y; Zhao L; Xiang M; Xu Y; Jiang X; Wang G; Wang L; Wang Z
    Biomaterials; 2021 Feb; 269():120388. PubMed ID: 33172606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment-Activated Nanoparticles Loaded with an Iron-Carbonyl Complex for Chemodynamic Immunotherapy of Lung Metastasis of Melanoma
    Zhai T; Zhong W; Gao Y; Zhou H; Zhou Z; Liu X; Yang S; Yang H
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39100-39111. PubMed ID: 34382406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogrammed IDO-Induced Immunosuppressive Microenvironment Synergizes with Immunogenic Magnetothermodynamics for Improved Cancer Therapy.
    Wang X; Yan B; Li H; Yuan J; Guo J; Wang S; Dai P; Liu X
    ACS Appl Mater Interfaces; 2024 Jun; 16(24):30671-30684. PubMed ID: 38843203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 14. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy.
    Ma J; Yuan H; Zhang J; Sun X; Yi L; Li W; Li Z; Fu C; Zheng L; Xu X; Wang X; Wang F; Yin D; Yuan J; Xu C; Li Z; Peng X; Wang J
    J Control Release; 2024 Jun; 370():501-515. PubMed ID: 38703950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.
    Wan Z; Sun J; Xu J; Moharil P; Chen J; Xu J; Zhu J; Li J; Huang Y; Xu P; Ma X; Xie W; Lu B; Li S
    Acta Biomater; 2019 May; 90():300-313. PubMed ID: 30930305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
    Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
    J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition.
    Zheng RR; Zhao LP; Huang CY; Cheng H; Yang N; Chen ZX; Cai H; Zhang W; Kong RJ; Li SY
    ACS Nano; 2023 Jun; 17(11):9972-9986. PubMed ID: 37200049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
    Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
    J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ photothermal nano-vaccine based on tumor cell membrane-coated black phosphorus-Au for photo-immunotherapy of metastatic breast tumors.
    Huang D; Wu T; Lan S; Liu C; Guo Z; Zhang W
    Biomaterials; 2022 Oct; 289():121808. PubMed ID: 36137415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.